Galiximab

CAS No. 357613-77-5

Galiximab( —— )

Catalog No. M36728 CAS No. 357613-77-5

Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 375 Get Quote
5MG 687 Get Quote
10MG 937 Get Quote
25MG 1371 Get Quote
50MG 1812 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Galiximab
  • Note
    Research use only, not for human use.
  • Brief Description
    Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen.
  • Description
    Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    357613-77-5
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Smith SM, et, al. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul;54(7):1405-10.?
molnova catalog
related products
  • Sodium benzoate

    Sodium benzoate is a D-Amino Acid Oxidase Inhibitor.Sodium Benzoate is a Food Preservative.

  • Dextromethorphan

    Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.

  • Neurokinin A(4-10) T...

    Neurokinin A (4-10) TFA is a tachykinin NK2 receptor agonist.